10 Pfizer AI and data science leaders
All ten Pfizer AI leaders here hold current Pfizer titles, three at vice president level: a Head of Data Science and AI, a Head of AI/ML & Digital Sciences for Global Product Development, and a Head of Machine Learning Research. The rest sit closer to specific teams, from vaccines medical AI and R&D medical to quantitative and digital sciences and AI solution architecture, so a drug developer deciding where AI should report can compare several setups.
Professionals to explore
Christopher G. Prener
LinkedInExperience: Sr. Director, AI and Data Science Lead for R&D Medical · Pfizer
$1,010 per 30-minute call
Questions on AI in medical evidence generation suit Christopher G. Prener, Sr. Director, AI and Data Science Lead for R&D Medical at Pfizer since 2026. Other Pfizer titles include Medical Evidence Generation, Platform Team Lead (2025–2026), Director, RWE Digital Platforms (2024–2025) and Director, Vaccines RWE Biocurator Scientist (2022–2023), and Prener is Adjunct Faculty at the Brown School at Washington University in St. Louis.
Is this you? Claim your profile and get paid for calls.
Djork-Arné Clevert
LinkedInExperience: Vice President, Head of Machine Learning Research · Pfizer
$2,019 per 30-minute call
Djork-Arné Clevert, based in Berlin, has been Vice President, Head of Machine Learning Research at Pfizer since 2022 and is Principal Investigator at Explainable AI for Molecules - AiChemist MSCA DN Horizon Europe (since 2023) and AIDD-ITN (since 2021). At Bayer the titles were Head of Machine Learning Research, Director, Senior Research Fellow (2019–2022) and Senior Research Scientist (2015–2019), suiting questions on machine learning for molecular research.
Is this you? Claim your profile and get paid for calls.
Gaurav Jain
LinkedInExperience: Director and Head, AI/ML, Quantitative & Digital Sciences (AQDS) IND-PH · Pfizer
$673 per 30-minute call
Since 2025 Gaurav Jain has been Director and Head, AI/ML, Quantitative & Digital Sciences (AQDS) IND-PH at Pfizer, describing the work as developing and implementing digital health solutions for drug research. Jain was Senior Group Lead (2024–2025) and Group Lead (2021–2024) of Informatics and Predictive Sciences (IPS) at Biocon Bristol-Myers Squibb R&D center (BBRC), which suits questions on informatics and predictive science groups.
Is this you? Claim your profile and get paid for calls.
Kate Ostbye
LinkedInExperience: Senior Director, AI Innovation & Data Science · Pfizer
$808 per 30-minute call
In their own words, Kate Ostbye aims to build AI/ML solutions that accelerate development and give researchers and staff stuck in manual processes an "easy" button. Ostbye has been Senior Director, AI Innovation & Data Science at Pfizer since 2024, was Director, Enterprise Data Science and Machine Learning at Pfizer (2023–2024) and Seagen (2022–2023), and was Director, Programming Unit at Fred Hutch (2018–2022).
Is this you? Claim your profile and get paid for calls.
Krishna Praneeth Kilambi
LinkedInExperience: Director, AI ML Quantitative & Digital Sciences Lead · Pfizer
$673 per 30-minute call
Digital biomarkers and imaging data are good topics for Krishna Praneeth Kilambi, Director, AI ML Quantitative & Digital Sciences Lead at Pfizer since 2025, after Associate Director titles there in AI ML Quantitative & Digital Sciences (2023–2025) and Data Science, Digital Sciences & Translational Imaging Quantitative Sciences (2022–2023). Kilambi was Senior Scientist, Digital Biomarkers Data Science at Biogen (2020–2022).
Is this you? Claim your profile and get paid for calls.
Savvas Karagiannidis
LinkedInExperience: Head of AI Solution Design Architecture · Pfizer
$673 per 30-minute call
As Director/TL of AI Product Delivery & Methodology at Pfizer (2024–2025), Savvas Karagiannidis guided a team of Senior Data Scientists acting as AI/ML technology leads on solutions for internal functions; the current title is Head of AI Solution Design Architecture (since 2025). Karagiannidis was also Director of Data Science Commercial Excellence (2022–2024) and Data Science Manager (2020–2022) at Pfizer, suiting questions on commercial data science.
Is this you? Claim your profile and get paid for calls.
Subha Madhavan
LinkedInExperience: Vice President & Head of AI/ML & Digital Sciences, Global Product Development · Pfizer
$1,010 per 30-minute call
Vice President & Head of AI/ML & Digital Sciences, Global Product Development at Pfizer since 2022, Subha Madhavan describes leading AI/ML and Digital Sciences within Research & Development with a product mindset. Madhavan was Head of Data Science, Oncology R&D at AstraZeneca (2021–2022), a Board Member at Vivli (2023–2025) and a HIMSS forum leader on AI and machine learning in healthcare (2018–2021), a fit for questions on AI in drug development.
Is this you? Claim your profile and get paid for calls.
Suman Giri
LinkedInExperience: Vice President, Head of Data Science and AI · Pfizer
$1,010 per 30-minute call
Suman Giri has been Vice President, Head of Data Science and AI at Pfizer since 2024 and was Executive Director, Head of Data Science at Merck (2021–2024). Other roles were Director, Data Science & Consulting at CitiusTech (2019–2021), Data Science Manager at Highmark (2016–2019) and Data Scientist at Aetna, a CVS Health Company (2015–2016), so Giri can compare heading data science at Merck with heading data science and AI at Pfizer.
Is this you? Claim your profile and get paid for calls.
Timothy Lee Wiemken
LinkedInExperience: Head of Vaccines Medical AI and Innovation · Pfizer
$808 per 30-minute call
Head of Vaccines Medical AI and Innovation at Pfizer since 2026, Timothy Lee Wiemken has held other Pfizer titles since 2024, including Senior Director, Artificial Intelligence Acceleration Transformation Engineering (2026), Head, RWD Artificial Intelligence and Informatics (2025–2026), Senior Director and Lead, Operational Analytics (2025) and Senior Director, Real World Evidence Digital Platforms Team Lead (2024–2025), a fit for questions on AI for vaccines medical work.
Is this you? Claim your profile and get paid for calls.
Μαρία Γιάτσογλου
LinkedInExperience: Director, AIDA R&D AI and Data Science · Pfizer
$573 per 30-minute call
Μαρία Γιάτσογλου, based in Thessaloniki, Greece, has been Director, AIDA R&D AI and Data Science at Pfizer since 2025 and was Senior Manager, Data Scientist there (2021–2025). Lead Data Scientist at Dataviva (2020–2021) and data scientist roles at Veltio (now part of Dataviva) round out a hands-on path, useful for questions on moving R&D data scientists into AI leadership.
Is this you? Claim your profile and get paid for calls.
Choose the right perspective
For where AI should sit at the top, the three vice presidents fit: Suman Giri for a combined data science and AI organization, Subha Madhavan for product development, Djork-Arné Clevert for machine learning research. Medical and real-world evidence questions point to Timothy Lee Wiemken and Christopher G. Prener, commercial and delivery questions to Savvas Karagiannidis, and R&D quantitative and data science questions to Gaurav Jain, Krishna Praneeth Kilambi or Μαρία Γιάτσογλου.
Questions to take into the conversation
- 01How should machine learning research, product development AI and medical AI teams split work inside a drug company's R&D organization?
- 02What does it take to move real-world evidence platforms from analytics into AI tools that medical and vaccines teams use day to day?
- 03How do you decide which AI solutions to build centrally for internal functions and which to leave to individual research or commercial teams?
About this directory
This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot; roles marked former had ended by then. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.